We Believe in Expanding Cancer Advocacy and Support
Pfizer advocates for the cancer community to support the needs of all that are impacted by cancer along with the encouragement to join forces.
Supporting the needs of patients
We work closely with patient advocates, professional organizations, policy makers, and foundations to better understand the needs of patients, families, caregivers, and others impacted by cancer and find ways to meet those needs.
We encourage our partners to share best practices and work together to achieve patient-centric solutions. Our goal is to provide the educational, emotional, and psychosocial resources that can make a real difference in patient outcomes.
We also provide millions of dollars in grants each year to fund organizations that provide essential programs and services to patients coping with a wide range of cancers.
- Change the Odds: The American Cancer Society and Pfizer
The American Cancer Society (ACS) and Pfizer recently launched a new three-year initiative
The American Cancer Society (ACS) and Pfizer recently launched a new three-year initiative, “Change the Odds: Uniting to Improve Cancer Outcomes,” aimed at addressing cancer disparities and improving health outcomes in medically underrepresented communities across the United States. - Lung Cancer Profiles/United We Test Quest
Lung Cancer Profiles/United We Test Quest
Collaborated with 7 lung cancer patient advocacy organizations toincrease awareness and education. - AVON Foundation for Women
AVON Foundation for Women
Established a grants program with Avon Foundation to support people living with metastatic breast cancer. In 2015, Avon and Pfizer each contributed $500,000 in grants that were awarded to a total of 23 nonprofit organizations. - Breast Cancer: A Story Half Told
Breast Cancer: A Story Half Told
Partnered with 5 patient advocacy organizations, healthcare professionals, linguists, and employers to support women with breast cancer, including those with metastatic disease - Cancer Support Community (CSC)/The Leukemia & Lymphoma Society (LLS)
Cancer Support Community (CSC)/The Leukemia & Lymphoma Society (LLS)
Collaborated with the Chronic Myeloid Leukemia (CML) Patient Experience Registry to identify and understand the psychosocial and emotional needs of CML patients. - ASCO/Conquer Cancer Foundation (CCF)
ASCO/Conquer Cancer Foundation (CCF)
Supported the CancerLinQ initiative, a health information technology (HIT) platform designed to improve the quality and value of cancer care. - Union for International Cancer Control (UICC)
Union for International Cancer Control (UICC)
Supported a first-of-its-kind initiativeto address the unique challenges facing metastatic breast cancer (MBC) patients. - Susan G. Komen
Susan G. Komen
Supported the Komen Disparities initiative to reduce the difference in breast cancer outcomes between African-American and Caucasian women in the US.
PfizerForAll
Pfizer is fighting for 8 cancer breakthroughs by 2030
We're driving the breakthroughs of tomorrow while fighting against cancer today. The fight takes all of us. Start by answering a few questions to understand your own cancer risks at PfizerForAll.com.
Get Started DetailsJoining forces to speed advances and breakthrough medicines to patients
At Pfizer, we know we can’t go at it alone and are actively supporting the development of an emerging, highly networked ecosystem that will catalyze tomorrow’s health innovation.
This includes working with patient foundations, patients, government, payers, healthcare professionals, academia, and even some of our competitors in the biopharmaceutical industry.
Challenging our colleagues to do more
The Global Health Fellows (GHF) program is an international corporate volunteer program that places Pfizer colleagues in short-term fellowships with international development organizations. Fellows return with experience and relationships that help inform their ability to have an impact on pressing health concerns and to do business more efficiently.
Learn more about the Global Health Fellows program
Supporting women with metastatic breast cancer (MBC)
In 2015, to address the unique needs of MBC patients worldwide, Pfizer and the UICCa awarded grants totaling $760,000 to 20 organizations from 18 countries under a first-of-its-kind initiative, SPARCb-MBC Challenge.
The challenge aims to empower advocacy groups, hospital networks, support groups, and other organizations to close the gap in information, support, awareness, and policy between MBC and early stage disease, and support women diagnosed with metastatic breast cancer.
